Skip to content

HUMA

Humacyte, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.59
+1.83%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 11, 2026
EPS estimate
-$0.09
Revenue estimate
$769.4K

Latest reported

Last report date
Aug 12, 2026
EPS actual
-$0.16
EPS estimate
-$0.11
Revenue actual
$406.0K
Revenue estimate
$1.0M

Track record

Trailing twelve quarters

EPS beats (12Q)
5
EPS misses (12Q)
3
EPS in line (12Q)
4
Avg surprise (4Q)
-3.3%
Revenue beats (12Q)
1

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$1.50
PT range
$1.00 – $2.00
Analysts
2
2 Buy0 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 12, 2026-$0.11-$0.16Miss -41.04%$406.0K
May 13, 2026-$0.10-$0.09Beat 10.00%$495.0K
Mar 27, 2026-$0.13-$0.13In line$467.0K
Nov 12, 2025-$0.17-$0.14Beat 17.65%$753.0K
Mar 28, 2025-$0.23-$0.16Beat 30.43%$7.2M
Nov 8, 2024-$0.26-$0.33Miss -26.92%
May 10, 2024-$0.23-$0.29Miss -26.09%
Mar 22, 2024-$0.25-$0.24Beat 4.00%
Nov 9, 2023-$0.25-$0.25In line
Aug 14, 2023-$0.22-$0.22In line
May 12, 2023-$0.22-$0.22In line
Mar 24, 2023-$0.24-$0.21Beat 12.50%$5.0K

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026